Press release
Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to
"The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%."The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. However, inadequate reimbursement and rising healthcare cost limiting usage of novel diagnostic technologies are expected to restrain the growth of this market during the forecast period.
#Download Free PDF Sample Brochure of report Global Infectious Disease Diagnostics Market 2020 across with 170 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=323163
The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bio Merieux (France), Bio-Rad (US), and Roche (Switzerland).
"The assays, kits,& reagents segment accounted for the largest share in 2017."
Based on product & service, the infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages.
"Asia Pacific is projected to grow at the highest CAGR during the forecast period."
Geographically, Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Research Coverage:
The infectious disease diagnostics market in this report is segmented by product& service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches& approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
Place a direct purchase order and get 20% instant discount @ https://www.reportsnreports.com/purchase.aspx?name=323163
List of Tables
Table 1 New Tests Launched By Key Players
Table 2 Infectious Disease Diagnostics Market, By Product & Service, 2015-2022 (USD Million)
Table 3 Infectious Disease Diagnostic Assays, Kits, & Reagents Market, By Region, 2015-2022 (USD Million)
Table 4 North America: Infectious Disease Diagnostic Assays, Kits, & Reagents Market, By Country, 2015-2022 (USD Million)
Table 5 Infectious Disease Diagnostic Instruments Market, By Region, 2015-2022 (USD Million)
Table 6 North America: Infectious Disease Diagnostic Instruments Market, By Country, 2015-2022 (USD Million)
Table 7 Infectious Disease Diagnostic Services & Software Market, By Region, 2015-2022 (USD Million)
Table 8 North America: Infectious Disease Diagnostic Services & Software Market, By Country, 2015-2022 (USD Million)
Table 9 Infectious Diseases Diagnostics Market, By Technology, 2015-2022 (USD Million)
Table 10 Infectious Disease Diagnostics Market for Immunodiagnostics, By Region, 2015-2022 (USD Million)
Table 11 North America: Market for Immunodiagnostics, By Country, 2015-2022 (USD Million)
Table 12 Market for Clinical Microbiology, By Region, 2015-2022 (USD Million)
Table 13 North America: Market for Clinical Microbiology, By Country, 2015-2022 (USD Million)
Table 14 Market for PCR, By Region, 2015-2022 (USD Million)
List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation
Figure 6 Infectious Disease Diagnostics Market, By Product & Service, 2017 vs 2022
Figure 7 Market, By Disease Type, 2017 vs 2022
Figure 8 Market, By Technology, 2017 vs 2022
Figure 9 Market, By End User, 2017 vs 2022
Figure 10 Geographical Snapshot of the Market
Figure 11 Increasing Prevalence of Infectious Diseases is A Key Driver for the Market
Figure 12 Immunodiagnostics Technology Segment Accounted for the Largest Share of the Market in 2017
Figure 13 Assays, Kits & Reagents Will Continue to Dominate the Infectious Disease Diagnostics Market in 2022
Figure 14 Hospitals & Clinical Laboratories Accounted for the Largest Market Share in 2017
Figure 15 Market: Drivers, Restraints, and Opportunities
Get Discount (Use code MAR 20) @ https://www.reportsnreports.com/contacts/discount.aspx?name=323163
Connect Us for more information at sales@reportsandreports.com or Call Us + 1 888 391 5441
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to here
News-ID: 1992446 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…